Heterodimeric antibodies that bind CD3 and CD38
US11352442B2 · kind B2 · utility
1Cited by
127References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 22, 2019 |
| Grant date | Jun 7, 2022 |
| Priority date | — |
| Expiry date | Jul 10, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to heterodimeric antibodies that bind CD3 and CD38.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.